Alcohol policy reform in Australia: what can we learn from the evidence?

PubWeight™: 0.91‹?›

🔗 View Article (PMID 20402613)

Published in Med J Aust on April 19, 2010

Authors

Christopher M Doran1, Wayne D Hall, Anthony P Shakeshaft, Theo Vos, Linda J Cobiac

Author Affiliations

1: National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia. c.doran@unsw.edu.au

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64

Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70

Global patterns of mortality in young people: a systematic analysis of population health data. Lancet (2009) 7.05

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med (2013) 6.04

The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis (2014) 5.19

Opioid overdose deaths can occur in patients with naltrexone implants. Med J Aust (2007) 4.86

A systematic review of the global prevalence of low back pain. Arthritis Rheum (2012) 4.64

A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr (2003) 4.64

The long-term health consequences of child physical abuse, emotional abuse, and neglect: a systematic review and meta-analysis. PLoS Med (2012) 4.37

Exploring conditions under which it may be ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception. Addiction (2012) 3.99

Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet (2007) 3.97

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (2013) 3.65

Cost-effectiveness of interventions to reduce dietary salt intake. Heart (2010) 3.51

The demise of a planned randomised controlled trial in an urban Aboriginal medical service. Med J Aust (2002) 3.41

Global burden of disease 2005: call for collaborators. Lancet (2007) 2.64

Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust (2008) 2.63

The long-term effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up. Addiction (2002) 2.61

Reductions in child mortality levels and inequalities in Thailand: analysis of two censuses. Lancet (2007) 2.30

The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS One (2013) 2.17

Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med (2007) 2.10

Trends in disease burden in Germany: results, implications and limitations of the Global Burden of Disease study. Dtsch Arztebl Int (2014) 2.09

Meta-analysis of prevalence. J Epidemiol Community Health (2013) 2.03

Cost-effectiveness of interventions to prevent alcohol-related disease and injury in Australia. Addiction (2009) 2.01

Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: a meta-regression of factors that may predict outcome. Aust N Z J Psychiatry (2006) 1.98

Patterns of antipsychotic medication use in Australia 2002-2007. Aust N Z J Psychiatry (2010) 1.86

Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias. Eur J Epidemiol (2005) 1.86

The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction (2012) 1.83

Excess Indigenous mortality: are Indigenous Australians more severely disadvantaged than other Indigenous populations? Int J Epidemiol (2007) 1.78

GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet (2012) 1.77

Estimated causes of death in Thailand, 2005: implications for health policy. Popul Health Metr (2010) 1.74

The burden of disease in Zimbabwe in 1997 as measured by disability-adjusted life years lost. Trop Med Int Health (2006) 1.72

Measuring the global burden of low back pain. Best Pract Res Clin Rheumatol (2010) 1.71

Cost-effectiveness of interventions to promote physical activity: a modelling study. PLoS Med (2009) 1.64

Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged > or =70. BMJ (2005) 1.58

The enhancement use of neuropharmaceuticals: more scepticism and caution needed. Addiction (2010) 1.58

From "our world" to the "real world": Exploring the views and behaviour of policy-influential Australian public health researchers. Soc Sci Med (2011) 1.55

Per capita alcohol consumption in Australia: will the real trend please step forward? Med J Aust (2010) 1.54

Multiple genetic tests for susceptibility to smoking do not outperform simple family history. Addiction (2009) 1.51

Priority setting in health: origins, description and application of the Australian Assessing Cost-Effectiveness initiative. Expert Rev Pharmacoecon Outcomes Res (2008) 1.50

Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception? Addiction (2012) 1.49

The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS One (2013) 1.49

Sociodemographic correlates of antidepressant utilisation in Australia. Med J Aust (2009) 1.47

Epidemiological modelling (including economic modelling) and its role in preventive drug therapy. Med J Aust (2002) 1.47

How can we reduce alcohol-related road crash deaths among young Australians? Med J Aust (2010) 1.42

Burden of stroke in indigenous Western Australians: a study using data linkage. Stroke (2011) 1.42

Television viewing time and reduced life expectancy: a life table analysis. Br J Sports Med (2012) 1.41

Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend (2010) 1.40

UK classification of cannabis: is a change needed and why? Lancet (2007) 1.38

A comparative risk assessment for South Africa in 2000: towards promoting health and preventing disease. S Afr Med J (2007) 1.37

The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction (2014) 1.35

The global burden of musculoskeletal conditions for 2010: an overview of methods. Ann Rheum Dis (2014) 1.32

Smart drugs "as common as coffee": media hype about neuroenhancement. PLoS One (2011) 1.27

Review of the long-term disability associated with hip fractures. Inj Prev (2011) 1.27

The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. J Child Psychol Psychiatry (2014) 1.24

Substance use and the adolescent brain: a toxic combination? J Psychopharmacol (2007) 1.23

Estimating the burden of disease attributable to interpersonal violence in South Africa in 2000. S Afr Med J (2007) 1.22

Economic evaluation of skin cancer prevention in Australia. Prev Med (2009) 1.21

Epidemiology of alcohol-related burden of disease among Indigenous Australians. Aust N Z J Public Health (2010) 1.17

Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010. J Child Psychol Psychiatry (2013) 1.16

A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion. Addiction (2015) 1.16

Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS One (2012) 1.15

Assessing Cost-Effectiveness--Mental Health: introduction to the study and methods. Aust N Z J Psychiatry (2004) 1.13

Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence. Addict Behav (2010) 1.12

The economic analysis of prevention in mental health programs. Annu Rev Clin Psychol (2011) 1.12

Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J (2003) 1.10

Interpersonal violence: an important risk factor for disease and injury in South Africa. Popul Health Metr (2010) 1.10

Cost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimen. Cost Eff Resour Alloc (2005) 1.09

Reaching "an audience that you would never dream of speaking to": influential public health researchers' views on the role of news media in influencing policy and public understanding. J Health Commun (2013) 1.08

Sustainability and cost of a community-based strategy against Aedes aegypti in northern and central Vietnam. Am J Trop Med Hyg (2010) 1.08

The association between four citation metrics and peer rankings of research influence of Australian researchers in six fields of public health. PLoS One (2011) 1.07

Assessing cost-effectiveness in obesity (ACE-obesity): an overview of the ACE approach, economic methods and cost results. BMC Public Health (2009) 1.06

'Occasional' and 'social' smokers: potential target groups for smoking cessation campaigns? Aust N Z J Public Health (2006) 1.05

Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology (2015) 1.04

Galvanizers, guides, champions, and shields: the many ways that policymakers use public health researchers. Milbank Q (2011) 1.04

The national burden of road traffic injuries in Thailand. Popul Health Metr (2011) 1.03

Burden of disease and injury in Aboriginal and non-Aboriginal populations in the Northern Territory. Med J Aust (2004) 1.03

Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013. Neuroepidemiology (2015) 1.02

The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment. BMC Med (2013) 1.02

Projecting the burden of diabetes in Australia--what is the size of the matter? Aust N Z J Public Health (2009) 1.02

Evaluating the quality of national mortality statistics from civil registration in South Africa, 1997-2007. PLoS One (2013) 1.02

Cost-effectiveness of Weight Watchers and the Lighten Up to a Healthy Lifestyle program. Aust N Z J Public Health (2010) 1.01

Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction (2009) 1.01